Suchergebnisse - "Wenziger, Cachet"

PubPharm (25)

1

Assessing the Burden and Cost of COVID-19 Across Variants in Commercially Insured Immunocompromised Populations in the United States : Updated Results and Trends from the Ongoing EPOCH-US Study

enthalten in: Advances in therapy | 2024

von Ketkar, A. | Willey, V. | Glasser, L. | +7

2

Assessing the Burden and Cost of COVID-19 Across Variants in Commercially Insured Immunocompromised Populations in the United States: Updated Results and Trends from the Ongoing EPOCH-US Study

enthalten in: Advances in therapy | 2024

von Ketkar, A. | Willey, V. | Glasser, L. | +7

3

Assessing the risk and costs of COVID-19 in immunocompromised populations in a large United States commercial insurance health plan : the EPOCH-US Study

enthalten in: Current medical research and opinion | 2023

von Ketkar, A. | Willey, V. | Pollack, M. | +7

4

Serum Creatinine-to-Cystatin-C Ratio as a Potential Muscle Mass Surrogate and Racial Differences in Mortality

enthalten in: Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation | 2023

von Rizk, J. | Streja, E. | Wenziger, C. | +4

5

Association of serum potassium with decline in residual kidney function in incident hemodialysis patients

enthalten in: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association | 2022

von Arif, Y. | Wenziger, C. | Hsiung, J. | +8

6

Novel Protein to Phosphorous Ratio Score Predicts Mortality in Hemodialysis Patients

enthalten in: Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation | 2022

von Bielopolski, D. | Wenziger, C. | Steinmetz, T. | +3

7

Warfarin Use, Stroke, and Bleeding Risk among Pre-Existing Atrial Fibrillation US Veterans Transitioning to Dialysis

enthalten in: Nephron | 2022

von Sy, J. | Wenziger, C. | Marroquin, M. | +3

8

Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Use Associated with Reduced Mortality and Other Disease Outcomes in US Veterans with COVID-19

enthalten in: Drugs | 2022

von Rizk, J. | Wenziger, C. | Tran, D. | +4

9

Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Use Associated with Reduced Mortality and Other Disease Outcomes in US Veterans with COVID-19

enthalten in: Drugs | 2021

von Rizk, J. | Wenziger, C. | Tran, D. | +4

10

Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Use Associated with Reduced Mortality and Other Disease Outcomes in US Veterans with COVID-19

enthalten in: Drugs | 2021

von Rizk, J. | Wenziger, C. | Tran, D. | +4